BGI
ORKA

B Group Inc’s Oruka Therapeutics ORKA Stock Holding History

B Group Inc’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.68M Hold
75,000
– – 2.73% 14
2025
Q4 		$2.27M Hold
75,000
– – 1.68% 14
2025
Q3 		$1.44M Hold
75,000
– – 1.06% 16
2025
Q2 		$841K Buy
75,000
+16,785
+29% +$175K 0.65% 17
2025
Q1 		$597K Buy
58,215
+38,215
+191% +$477K 0.51% 18
2024
Q4 		$388K Buy
+20,000
New +$488K 0.24% 17

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

B Group Inc's ORKA Position: Q1 2026 in Review

B Group Inc held its Oruka Therapeutics (ORKA) position steady in Q1 2026 at 75,000 shares worth $3.68M. The position accounts for 2.73% of the portfolio, ranked #14.

B Group Inc first reported a position in ORKA in Q4 2024 and has held it in 6 quarters since. 184 funds tracked by Wall St. Rank hold ORKA as of Q1 2026.

  • B Group Inc held 75,000 shares of Oruka Therapeutics worth $3.68M as of Q1 2026.
  • B Group Inc left its Oruka Therapeutics share count unchanged in Q1 2026.
  • Oruka Therapeutics made up 2.73% of B Group Inc's portfolio in Q1 2026, its #14 holding.
  • B Group Inc first reported a position in Oruka Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • 184 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q1 2026.

Based on B Group Inc's 13F filing for Q1 2026, filed 15 May 2026.